OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $150,000 | -63.8% | 21,470 | -48.2% | 0.09% | -65.2% |
| Q3 2021 | $414,000 | -7.6% | 41,420 | +31.1% | 0.26% | -5.9% |
| Q2 2021 | $448,000 | +17.9% | 31,590 | +36.4% | 0.27% | +0.7% |
| Q1 2021 | $380,000 | +35.7% | 23,160 | +71.2% | 0.27% | +1.9% |
| Q4 2020 | $280,000 | +101.4% | 13,525 | -25.7% | 0.26% | +82.8% |
| Q3 2020 | $139,000 | -3.5% | 18,200 | +5.2% | 0.14% | -0.7% |
| Q2 2020 | $144,000 | – | 17,300 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |